Identification and Validation of a Potential Prognostic 7-lncRNA Signature for Predicting Survival in Patients with Multiple Myeloma

Table 1

Clinical information of two datasets.

Characteristic		Training datasets ()	Validation datasets ()		GSE57317 ()
Survival status	Living	92	94	0.969	43
	Dead	35	34		12
Survival time	High risk	31.73	26.02		17
	Low risk	37.53	34.69		23.47
Mol. subtype	CD-1: CCND1/CCND3 (group 5)	11	11	0.882	5
	CD-2: CCND1/CCND3 (group 6)	21	21		13
	HY: hyperdiploid	28	38		13
	LB: low bone disease	16	15		6
	MF: MAF/MAFB	12	9		2
	MS: MMSET	23	21		3
	PR: proliferation	16	13		13